Skip to main content

Important Coronavirus Update from Dean Reece

March 25, 2020

Dear UMSOM Community:

E. Albert Reece, MD, PhD, MBAAs we continue to move forward in these challenging times, I would like to bring you a message of encouragement and hope. First and foremost, please be assured and confident that we are, and will continue to do, everything we can to ensure the health and well-being of all within our SOM community. Significant steps are being taken by the State of Maryland, the University of Maryland Medical System, the University of Maryland, Baltimore, and the School of Medicine to ensure that everyone is healthy and safe. Second, I want to encourage each of you to use this time when you are working remotely to advance the mission areas of the School of Medicine -- research, clinical care, education, and community impact. I am convinced that if we focus on these priorities, when we resume our normal schedules, we will quickly be able to realize that there was little or no "lost time."  As you will see below, much work is being done by members of our academic community to focus on this COVID-19 pandemic.

New Executive Order

Governor HoganGovernor Hogan has issued a new Executive Order that closes all non-essential businesses in the State of Maryland.  The new restriction reflects the growing number of cases in the state and the need for residents to stay at home unless it is absolutely necessary to go out.  As we continue to implement Step 2 Activation level for all of our employees, it is critical for everyone to follow all of the state and federal laws that are now in place that restrict travel and social distancing.   The Governor's Office has created a new website that provides official information for the State of Maryland at

Update from UMMS

Dr. SunthaAs part of the latest announcement, Gov. Hogan reiterated that all health care workers  -- including those employed by the University of Maryland Medical System -- are essential and will continue to serve the health care needs of the people of Maryland. Other health care related businesses that will continue to operate include pharmacies, home health care companies, manufactures and distributors of medical equipment and supplies, senior living facilities, diagnostic facilities, rehab facilities and offices of health care providers. ‚ÄčDr. Suntha has acknowledged this as a further indication of the vital role our Medical System plays in caring for the communities we serve. Our patients and communities are counting on us and we will be there to answer the call.

Update from UMB/UMSOM

Bruce Jarrell, MDPresident Bruce Jarrell announced yesterday that the campus will now move to an elevated level for our research activities, from Moderate Research Restrictions to Severe Research Restrictions. In sum, as stated in the Basic Science Research policy document issued last week, Severe Research Restrictions means that "we expect that you will curtail all activities not critical to maintaining animals, unique reagents/cell lines and essential equipment, at which point only 2-3 essential personnel (designated by the Principal Investigator) will be allowed in the lab and should be according to a defined employee schedule that ensures appropriate staggering."  The UMSOM is supportive of the UMB decision to restrict research in accordance with the Governor's mandate.  The UMSOM is working with the Campus and has developed further guidelines regarding the use of laboratory research.  The new guidelines, which were sent to all principal investigators, describe further restrictions as well as exceptions for certain laboratories.  These exceptions include laboratories involved in COVID-19 research, critical ongoing experiments, and those that have equipment requiring maintenance.  As previously noted, all UMB grant support services will continue to operate as is.  New grant submissions should continue to be a priority.

Faculty Research and Involvement in COVID-19

Dr. NeuzilKathleen Neuzil, MD, MPH, FIDSA, the Myron M. Levine, MD Distinguished Professor in Vaccinology, and Director, Center for Vaccine Development and Global Health (CVD), is part of a leadership team working with the National Institute of Allergy and Infectious Diseases (NIAID), to test vaccines and therapies at sites across the country. CVD is part of NIAID’s Vaccine and Treatment Evaluation Unit Network, one of nine sites researching vaccines and other therapies for COVID-19. The first Phase 1 trial of a vaccine began last week in Seattle, and Dr. Neuzil continues to work with infectious disease experts on the launch of additional trials. In addition, CVD’s Karen Kotloff, MD, Professor of Pediatrics and Head of the Pediatric Infectious Disease Division, and Justin Ortiz, MD, Associate Professor of Medicine-- are the principal investigators on a trial to study the efficacy of an antiviral therapy for treating COVID19.

Dr. ChenWilbur Chen, MD, Associate Professor of Medicine and an adult infectious disease specialist and David Marcozzi, MD, MD, MHS-CL, FACEP, Associate Professor of Emergency Medicine and Head of the Incident Command for the University of Maryland Medical System, are both serving on Governor Larry Hogan’s COVID-19 response taskforce.

They are advising top state officials about the illness, treatment and containment.


Dr. GalloRobert C. Gallo, MD, the Homer and Martha Gudelsky Professor in Medicine, Co-founder & Director, Institute of Human Virology at the University of Maryland School of Medicine and Co-Founder and Chairman of the International Scientific Leadership Board of the Global Virus Network, helped facilitate the delivery of 1,000 coronavirus tests to Baltimore. The tests, approved last week for marketing and use in the U.S. by the Food and Drug Administration, were donated by a company in China and arrived in Baltimore on Saturday. On Monday, Dr. Gallo was making arrangements for their distribution through the Maryland Department of Health.


Dr. BaleA new UMSOM study looks at the health toll of stress brought on by the COVID-19 pandemic. Tracy Bale, PhD, Professor of Pharmacology and Director of the Center for Epigenetic Research in Child Health & Brain Development at UMSOM, published her study in the journal Nature Communications.  It outlines a biological mechanism for how a father’s experience with stress can influence fetal brain development in the womb. She and her research team found the effects of paternal stress can be transferred to offspring through changes in the extracellular vesicles that then interact with maturing sperm. The news release on Dr. Bale’s research provides important tips for managing stress while we are all working at home and maintaining safe social distancing.


Dr. FriemanMatt Frieman, PhD, Professor of Microbiology and Immunology at UMSOM, continues his important work on testing potential new therapies to treat COVID-19. He and his colleagues published a paper on Monday in the journal Nature Nanotechnology that provides insights from the field of nanomedicine into the efficacy of chloroquine to treat the COVID-19. He also continues to be quoted extensively in the media on his coronavirus expertise and his work studying this novel coronavirus. Here are his latest insights in the Atlantic.

In closing, I want to reinforce my points of encouragement and extend my best wishes to each of you to remain optimistic.  I am confident that each of us can continue to demonstrate the courage and relentless spirit that I have seen countless times in the UMSOM community when we are faced with adversity.  Thank you again for everything that you do.

E. Albert Reece, MD, PhD, MBA
Executive Vice President for Medical Affairs, UM Baltimore
John Z. and Akiko K. Bowers Distinguished Professor
Dean, University of Maryland School of Medicine





Office of Public Affairs
655 West Baltimore Street
Bressler Research Building 14-002
Baltimore, Maryland 21201-1559

Contact Media Relations
(410) 706-5260

Related stories

    Thursday, November 19, 2020

    Promising Results Seen in Pfizer/BioNTech COVID-19 Vaccine After Phase 1 Trial by University of Maryland School of Medicine

    Just six months after beginning a clinical development program that first enrolled here at the University of Maryland School of Medicine (UMSOM), Pfizer and BioNTech report interim results showing an mRNA COVID-19 vaccine had no serious safety concerns and has been found to be 95 percent effective in protecting individuals from COVID-19.

    Tuesday, June 02, 2020

    UM School of Medicine’s Institute of Human Virology Awarded Grants to Strengthen COVID-19 Response in Sub-Saharan Africa

    The Center for International Health, Education and Biosecurity (Ciheb) at the University of Maryland School of Medicine’s Institute of Human Virology was awarded $4 million from the U.S. Centers for Disease Control and Prevention (CDC) to support coronavirus disease 2019 (COVID-19) response activities in Botswana, Nigeria, Malawi, and Mozambique.

    Monday, June 01, 2020

    In A COVID-19 World, Another Threat to the Health of Our Children

    In the U.S., our children rarely fall ill to grave infections because they are protected by vaccines. Serious illnesses like measles, mumps, congenital rubella syndrome, chickenpox, diphtheria, tetanus, whooping cough, rotavirus diarrhea, hepatitis (A and B), polio and bacterial meningitis are all preventable through routine childhood vaccinations.

    Tuesday, May 05, 2020

    UM School of Medicine is First in U.S. to Test Unique RNA Vaccine Candidate for COVID-19

    In a significant development in the global effort to discover a safe and effective vaccine for COVID-19, researchers at the University of Maryland School of Medicine (UMSOM) became the first in the U.S. to begin testing experimental COVID-19 vaccine candidates developed by Pfizer and BioNTech. The research, funded by Pfizer Inc., will study the safety, efficacy, and dosing of an experimental mRNA -based vaccine.

    Thursday, April 23, 2020

    UM School of Medicine Researchers Test Remdesivir as Potential Therapy for COVID-19 Patients

    Researchers at the University of Maryland School of Medicine (UMSOM) are testing the effectiveness of the investigational antiviral drug remdesivir in hospitalized adult patients with SARS-CoV-2 (COVID-19). The randomized controlled clinical trial is evaluating the safety and effectiveness of the drug, and it is part of a national study funded by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH).

    Friday, April 10, 2020

    University of Maryland School of Medicine Launches New Large Scale COVID-19 Testing Initiative

    University of Maryland School of Medicine (UMSOM) Dean E. Albert Reece, MD, PhD, MBA, announced today the launch of a large-scale COVID-19 Testing Initiative that will significantly expand testing capability over the coming weeks, enabled by new funding of $2.5 million from the State of Maryland.

    Wednesday, April 01, 2020

    Important Coronavirus Update from Dean Reece 04-01

    I am sure you are aware of Governor Hogan’s Executive Order that requires all residents of Maryland to stay at home, except for essential activities. The Governor continues to emphasize that we are still just at the beginning of this crisis in Maryland. While the State has been taking the lead with early containment efforts, we are now at a critical point. Each of our actions can lessen the expected surge in cases over the next few weeks.

    Wednesday, March 25, 2020

    Kids & COVID-19 Website Provides Resources for Pediatric Healthcare Providers and Families

    The University of Maryland School of Medicine has launched a special COVID-19 website for pediatric healthcare providers and practices, parents, and children. This resource brings together important research, professional guidance for pediatric practices, and practical tips for parents and caregivers.

    Tuesday, February 25, 2020

    Washington Post Visits UM School of Medicine Laboratories, Meets with Scientists About Coronavirus

    Result is front-page feature coverage of UMSOM’s leading work in studying the Virus

    Wednesday, January 29, 2020

    University of Maryland School of Medicine Mobilizes Virus Experts to prepare for Potential Coronavirus Outbreak

    As public health officials around the world are monitoring a new coronavirus strain (2019-nCoV) first identified in the Wuhan City, Hubei Province, China, the University of Maryland School of Medicine (UMSOM) is mobilizing its physicians and scientists in the UMSOM’s Center for Vaccine Development and Global Health (CVD), and in its Department of Microbiology & Immunology, to study the virus and test potential vaccines and other therapies. In addition, the UMSOM is collaborating with the University of Maryland Medical Center (UMMC) on rapid response and preparedness planning in the event of a growing outbreak.